Skip to main content

Advertisement

Log in

Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Anderson WF, Jatoi I, Devesa SS, 2005. Distinct breast cancer incidence and prognostic patterns in the NCI’s SEER program: suggesting a possible link between aetiology and outcome Breast Cancer Res Treat 90:127–137

    Article  PubMed  Google Scholar 

  2. Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente C, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R, 1981. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast N Engl J Med 305:6–11

    Article  PubMed  CAS  Google Scholar 

  3. Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, Galimberti V, Rasponi A, Di Re E, Squicciarini P, 1990. Quadrantectomy versus lumpectomy for small size breast cancer Eur J Cancer 26:671–673

    Article  PubMed  CAS  Google Scholar 

  4. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T, 1993. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast N Engl J Med 328:1587–1591

    Article  PubMed  CAS  Google Scholar 

  5. Moliterni A, Bonadonna G, Valagussa P, Ferrari L, Zambetti M, 1991. Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes J Clin Oncol 9:1124–1130

    PubMed  CAS  Google Scholar 

  6. Buzzoni R, Bonadonna G, Valagussa P, Zambetti M, 1991. Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes J Clin Oncol 9:2134–2140

    PubMed  CAS  Google Scholar 

  7. Falkson G, Gelman RS, Pandya KJ, Osborne CK, Tormey D, Cummings FJ, Sledge GW, Abeloff MD, 1998. Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment J Clin Oncol 16:1669–1676

    PubMed  CAS  Google Scholar 

  8. Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJM, Retsky MW, Valagussa P, Bonadonna G, 2005. Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumour dormancy and mastectomy-driven acceleration of the metastatic process Ann Oncol 16:1449–1457

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Romano Demicheli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demicheli, R., Bonadonna, G., Greco, M. et al. Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005. Breast Cancer Res Treat 97, 341–343 (2006). https://doi.org/10.1007/s10549-005-9128-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-005-9128-1

Keywords

Navigation